When ‘Too Good to Be True’ Really Is Too Good to Be True: FTC Settles With NextMed Regarding Deceptive Advertising Practices

The Federal Trade Commission (“FTC”) has reached a settlement with NextMed (also known as Southern Health Solutions, Inc.), resolving allegations that the telehealth company misled consumers through deceptive advertising, billing, and cancellation practices tied to weight-loss programs involving GLP-1 medications such as Wegovy and Ozempic. The FTC also named the company’s founder, Robert Epstein and… Continue Reading